Genomic determinants of resistance to anti-BCMA chimeric antigen receptor T-cell (CART) therapies in patients with relapsed/refractory multiple myeloma Meeting Abstract

  

Authors:	Maura, F.; Freeman, C. L.; Lee, H.; Maclachlan, K. H.; Durante, M.; Ziccheddu, B.; Menges, M.; Diamond, B.; Papadimitriou, M.; Silva, A. S.; Sudalagunta, P. R.; Leblay, N.; Ahn, S.; Fuller, E.; Briercheck, E.; Agius, P.; Hansen, D. K.; Song, X.; Zhao, X.; Meads, M. B.; Teer, J.; Firestone, R. S.; Garces, J. J.; Jelinek, T.; Baz, R.; Alsina, M.; Ramasubramanian, A.; Smith, E.; Giralt, S.; Mailankody, S.; Neri, P.; Usmani, S. Z.; Locke, F.; Bahlis, N. J.; Landgren, O.; Shain, K. H.
Abstract Title:	Genomic determinants of resistance to anti-BCMA chimeric antigen receptor T-cell (CART) therapies in patients with relapsed/refractory multiple myeloma
Meeting Title:	66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	144
Issue:	Suppl. 1
Meeting Dates:	2024 Dec 7-10
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-05
Start Page:	247
End Page:	249
Language:	English
ACCESSION:	WOS:001414317000047
DOI:	10.1182/blood-2024-201288
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/225347